Wendell Jones, Ph.D. | September 27, 2018

Immune Landscape Signatures from Gene Expression Analysis of Human Tumors

Signatures characterizing key immune cell subtypes, pathways, and individual genes
Speaker: Wendell Jones, Ph.D.

At Q2 Solutions | EA Genomics, we have investigated immune expression signatures associated with different immune subtypes and processes, and further categorized these signatures based on their biological origin with emphasis on identifying those signatures having importance and ability to predict patient response-to-therapy and overall survival in multiple tumor indications.

Download our presentation, given at the 2018 PMWC at Duke University, to learn more about the detection of Immune Landscape Signatures for characterization of tumor microenvironment and response to therapy.

Related Services:
Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy

Gene expression and analysis for detection of 15 Immune Landscape Signatures

Tumor Mutational Burden (TMB) Assay for Response to Immunotherapy

TMB assay utilizing whole exome sequencing (WES) methodology and proprietary variant analysis compendium

T-cell Receptor (TCR) Sequencing Assay for Characterization of Adaptive Immune Response

Detects TCRβ and TCRγ clonotypes expressed at the mRNA level

Microsatellite Instability Assay for Response to Immunotherapy

MSI assay for sensitive detection of 5 mononucleotide repeat markers in tumor FFPE specimens

Genomic Based Solutions for Your Immuno-oncology Drug Development Needs

Genomics-based biomarker approach

Read More